Laboratorio Reig Jofre, S.A. (RJF.MC)
EUR 2.73
(-0.36%)
EUR 2.73
(-0.36%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 9.4 Million EUR | 16.04% |
| 2022 | 8.1 Million EUR | 59.21% |
| 2021 | 5.09 Million EUR | -10.23% |
| 2020 | 5.67 Million EUR | 14.77% |
| 2019 | 4.94 Million EUR | -46.67% |
| 2018 | 9.26 Million EUR | 4.96% |
| 2017 | 8.82 Million EUR | 15.01% |
| 2016 | 7.67 Million EUR | -12.27% |
| 2015 | 8.74 Million EUR | 279.04% |
| 2014 | 2.3 Million EUR | 142.22% |
| 2013 | 953 Thousand EUR | 15983.33% |
| 2012 | -6000.00 EUR | -100.04% |
| 2011 | 16.06 Million EUR | 171.03% |
| 2010 | -22.61 Million EUR | 49.63% |
| 2009 | -44.9 Million EUR | -3111.87% |
| 2008 | 1.49 Million EUR | -61.18% |
| 2007 | 3.84 Million EUR | -15.56% |
| 2006 | 4.54 Million EUR | 21.08% |
| 2005 | 3.75 Million EUR | 22.9% |
| 2004 | 3.05 Million EUR | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q3 | 2.48 Million EUR | 8.88% |
| 2024 Q1 | 3.26 Million EUR | 112.43% |
| 2024 Q2 | 2.27 Million EUR | -30.25% |
| 2023 Q1 | 3.82 Million EUR | 0.0% |
| 2023 Q3 | 2.19 Million EUR | 17.99% |
| 2023 FY | 9.4 Million EUR | 16.04% |
| 2023 Q2 | 1.85 Million EUR | -51.43% |
| 2023 Q4 | 1.53 Million EUR | -29.9% |
| 2022 Q4 | 3.82 Million EUR | 5522.06% |
| 2022 FY | 8.1 Million EUR | 59.21% |
| 2022 Q3 | 68 Thousand EUR | 0.0% |
| 2021 Q3 | 1.54 Million EUR | 1857.95% |
| 2021 Q2 | -88 Thousand EUR | -102.41% |
| 2021 Q1 | 3.65 Million EUR | 1015.24% |
| 2021 FY | 5.09 Million EUR | -10.23% |
| 2021 Q4 | -25 Thousand EUR | -101.62% |
| 2020 Q3 | 1.48 Million EUR | 158.36% |
| 2020 FY | 5.67 Million EUR | 14.77% |
| 2020 Q1 | 3.28 Million EUR | 23.2% |
| 2020 Q2 | 574 Thousand EUR | -82.54% |
| 2020 Q4 | 328 Thousand EUR | -77.88% |
| 2019 Q1 | 2.43 Million EUR | -51.95% |
| 2019 FY | 4.94 Million EUR | -46.67% |
| 2019 Q4 | 2.66 Million EUR | 440.31% |
| 2019 Q3 | -784 Thousand EUR | -224.9% |
| 2019 Q2 | 627.71 Thousand EUR | -74.17% |
| 2018 FY | 9.26 Million EUR | 4.96% |
| 2018 Q1 | 2.24 Million EUR | -65.22% |
| 2018 Q4 | 5.05 Million EUR | 307.04% |
| 2018 Q3 | 1.24 Million EUR | 71.26% |
| 2018 Q2 | 725.54 Thousand EUR | -67.62% |
| 2017 FY | 8.82 Million EUR | 15.01% |
| 2017 Q4 | 6.44 Million EUR | 1877.55% |
| 2017 Q3 | -362.38 Thousand EUR | -154.02% |
| 2017 Q2 | 670.84 Thousand EUR | -67.75% |
| 2017 Q1 | 2.08 Million EUR | -22.11% |
| 2016 Q3 | 1.7 Million EUR | 28.06% |
| 2016 Q4 | 2.67 Million EUR | 56.56% |
| 2016 FY | 7.67 Million EUR | -12.27% |
| 2016 Q1 | 1.96 Million EUR | 3711.98% |
| 2016 Q2 | 1.33 Million EUR | -32.17% |
| 2015 FY | 8.74 Million EUR | 279.04% |
| 2015 Q2 | 1.91 Million EUR | -63.58% |
| 2015 Q3 | 1.52 Million EUR | -20.35% |
| 2015 Q4 | 51.52 Thousand EUR | -96.62% |
| 2015 Q1 | 5.25 Million EUR | 2527.42% |
| 2014 Q1 | 2.51 Million EUR | 306.48% |
| 2014 FY | 2.3 Million EUR | 142.22% |
| 2014 Q4 | -216.6 Thousand EUR | -116.57% |
| 2014 Q3 | 1.3 Million EUR | 200.46% |
| 2014 Q2 | -1.3 Million EUR | -151.65% |
| 2013 Q3 | -208 Thousand EUR | 58.23% |
| 2013 Q4 | -1.22 Million EUR | -486.54% |
| 2013 FY | 953 Thousand EUR | 15983.33% |
| 2013 Q1 | 2.88 Million EUR | -67.31% |
| 2013 Q2 | -498 Thousand EUR | -117.29% |
| 2012 Q1 | 2.08 Million EUR | -86.22% |
| 2012 Q2 | -10.9 Million EUR | -622.32% |
| 2012 Q3 | 8.53 Million EUR | 178.27% |
| 2012 Q4 | 8.81 Million EUR | 3.23% |
| 2012 FY | -6000.00 EUR | -100.04% |
| 2011 Q1 | 2.24 Million EUR | 0.0% |
| 2011 Q4 | 15.15 Million EUR | 0.0% |
| 2011 FY | 16.06 Million EUR | 171.03% |
| 2011 Q2 | -1.33 Million EUR | -159.35% |
| 2010 Q1 | 1.76 Million EUR | 0.0% |
| 2010 Q2 | -984 Thousand EUR | -155.69% |
| 2010 FY | -22.61 Million EUR | 49.63% |
| 2009 Q1 | 1.04 Million EUR | 0.0% |
| 2009 FY | -44.9 Million EUR | -3111.87% |
| 2008 FY | 1.49 Million EUR | -61.18% |
| 2007 FY | 3.84 Million EUR | -15.56% |
| 2006 FY | 4.54 Million EUR | 21.08% |
| 2005 FY | 3.75 Million EUR | 22.9% |
| 2004 FY | 3.05 Million EUR | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Almirall, S.A. | -38.47 Million EUR | 124.45% |
| Faes Farma, S.A. | 91.9 Million EUR | 89.764% |